Deposition of Inhaled Levofloxacin in Cystic Fibrosis Lungs Assessed by Functional Respiratory Imaging

• Main Authors: Carsten Schwarz (Author), Claudio Procaccianti (Author), Benjamin Mignot (Author), Hosein Sadafi (Author), Nicolas Schwenck (Author), Xabier Murgia (Author), Federico Bianco (Author)
• Format: Book
• Published: MDPI AG, 2021-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Pulmonary infections caused by <i>Pseudomonas aeruginosa</i> (PA) represent the leading cause of pulmonary morbidity in adults with cystic fibrosis (CF). In addition to tobramycin, colistin, and aztreonam, levofloxacin has been approved in Europe to treat PA infections. Nevertheless, no...